← SynDRA
homoveratrylamine
SynDRA canonical compound SYN0078997 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
| Mechanism of action | monoamine oxidase inhibitor |
Mechanisms of action (all sources)
- monoamine oxidase inhibitor
Cross-references
Synonyms
- 3,4-Dimethoxyphenethylamine
- 3,4-Dimethoxyphenylethylamine
- 2-(3,4-Dimethoxyphenyl)ethylamine
- Benzeneethanamine, 3,4-dimethoxy-
- Dimethoxydopamine
- Dimethylmescaline
- DMPEA
- 3,4-Dimethoxybenzeneethanamine
- Dopamine dimethyl ether
- DIMPEA
- O,O-Dimethyldopamine
- 3,4-Di-O-methyldopamine
- 3,4-Dimethoxydopamine
- 2-(3,4-Dimethoxyphenyl)Ethan-1-Amine
- 3,4-Dimethoxyphenylethylamine(base)
- 3,4-Dimethoxy-beta-phenylethylamine
- beta-(3,4-Dimethyoxyphenyl)ethylamine
- NSC-16948
- 2-(3,4-Dimethoxy-phenyl)-ethylamine
- PHENETHYLAMINE, 3,4-DIMETHOXY-
- EINECS 204-376-9
- IQF9T435OP
- 3,4-Dimethoxyphenylethylamine (base)
- 3,4-Dimethoxy-.beta.-phenylethylamine
- BRN 0474393
- AI3-23876
- CHEBI:136995
- NSC-6328
- NSC-26152
- DOPAMINE IMPURITY C
- EC 204-376-9
- 4-13-00-02604 (Beilstein Handbook Reference)
- 2-(3,4-dimethoxyphenyl)-ethylamine
- DOPAMINE HYDROCHLORIDE IMPURITY C [EP IMPURITY]
- DOPAMINE HYDROCHLORIDE IMPURITY C (EP IMPURITY)
- O,ODimethyldopamine
- 3,4Dimethoxydopamine
- 3,4DiOmethyldopamine
Look up homoveratrylamine in the interactive SynDRA portal →